These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1984485)

  • 1. Syngeneic B lymphoma cells provide a unique stimulus to natural killer (NK) cells in genetically low-NK SJL/J mice.
    Lin TZ; Ponzio NM
    J Leukoc Biol; 1991 Jan; 49(1):48-57. PubMed ID: 1984485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-12-induced cytotoxicity against syngeneic B cell lymphomas of SJL/J mice.
    Wajchman J; Simmons WJ; Klein A; Koneru M; Ponzio NM
    Leuk Res; 2002 Jun; 26(6):577-90. PubMed ID: 12007506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell activity in reticulum-cell sarcomas of SJL/J mice. II. Analysis of RCS-associated NK activity.
    Fitzgerald KL; Ponzio NM
    Int J Cancer; 1981 Nov; 28(5):627-34. PubMed ID: 6171532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of hybrid Ia molecules on the cell surface of reticulum cell sarcomas that are undetectable on host SJL/J lymphocytes.
    Wilbur SM; Bonavida B
    J Exp Med; 1981 Mar; 153(3):501-13. PubMed ID: 6166700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarities between the syngeneic mixed lymphocyte response and lymphoma-induced T cell proliferation in SJL/J mice.
    Ponzio NM
    Behring Inst Mitt; 1983 May; (72):28-36. PubMed ID: 6085747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ia-restricted interaction between normal lymphoid cells and SJL lymphoma (RCS) leading to lymphokine production. I. Enhancement and suppression of antibody formation to TI antigens by supernatants and cells from cocultures of RCS and lymphoid cells.
    Hayama T; Nagler C; Umetsu DT; Chapman-Alexander J; Thorbecke GJ
    Cell Immunol; 1983 Jul; 79(1):134-49. PubMed ID: 6222793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell activity in reticulum-cell sarcomas of SJL/J mice. III. Characterization of the effector cells within RCS that mediate NK lysis.
    Fitzgerald KL; McMaster JS; Ponzio NM
    Int J Cancer; 1981 Nov; 28(5):635-45. PubMed ID: 7030971
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers.
    Kaminsky SG; Nakamura I; Cudkowicz G
    J Immunol; 1983 Apr; 130(4):1980-4. PubMed ID: 6833756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syngeneic response to SJL follicular center B cell lymphoma (reticular cell sarcoma) cells is primarily in V beta 16+ CD4+ T cells.
    Tsiagbe VK; Asakawa J; Miranda A; Sutherland RM; Paterson Y; Thorbecke GJ
    J Immunol; 1993 Jun; 150(12):5519-28. PubMed ID: 8099938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological demonstration of an allogeneic Ia.7 antigen on the cell surface of SJL/J-derived reticulum cell sarcomas.
    Wilbur SM; Marelli O; Bonavida B
    Cancer Res; 1983 Sep; 43(9):4266-70. PubMed ID: 6347368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell activity associated with reticulum cell neoplasms.
    Chang KS; Log T
    Int J Cancer; 1980 Mar; 25(3):405-16. PubMed ID: 6248470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of SJL T cell clones responsive to syngeneic lymphoma (RCS): RCS-specific clones are stimulated by activated B cells.
    DeKruyff RH; Brown PH; Thorbecke GJ; Ponzio NM
    J Immunol; 1985 Nov; 135(5):3581-6. PubMed ID: 2413126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells.
    Kumar V; Luevano E; Bennett M
    J Exp Med; 1979 Sep; 150(3):531-47. PubMed ID: 383877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
    LeFor AT; Eisenthal A; Rosenberg SA
    J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
    Lasky JL; Ponzio NM; Thorbecke GJ
    J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ia-restricted interaction of normal lymphoid cells and SJL lymphoma (reticulum cell sarcoma) leading to lymphokine production. II. Rapid production of antibody-enhancing factor, interleukin 2, and immune interferon.
    Ponzio NM; Hayama T; Nagler C; Katz IR; Hoffmann MK; Gilbert K; Vilcek J; Thorbecke GJ
    J Natl Cancer Inst; 1984 Feb; 72(2):311-20. PubMed ID: 6420599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic control of the natural killer cell activity in SJL and other strains of mice.
    Kaminsky SG; Nakamura I; Cudkowicz G
    J Immunol; 1985 Jul; 135(1):665-71. PubMed ID: 3923115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ia-restricted interaction of normal lymphoid cells and SJL lymphoma (reticulum cell sarcoma) leading to lymphokine production. III. Relative roles of reticulum cell sarcoma and normal lymphoid cells in lymphokine production.
    Hayama T; Ponzio NM; Nagler C; Vilcek J; Coico RF; Thorbecke GJ
    J Natl Cancer Inst; 1984 Feb; 72(2):321-31. PubMed ID: 6420600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties and characterization of a rat spleen cell-derived factor that induces resistance to natural killer cell lysis in YAC lymphoma cells.
    Saxena RK; Saxena QB; Adler WH
    J Immunol; 1988 Sep; 141(5):1782-7. PubMed ID: 2457628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E; Gunji Y; Herberman RB
    J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.